Emory University: Infections trials

The registry lists 14 Infections studies with Emory University as lead sponsor. 1 are open to participants now and 2 have results posted.

Early Phase 1 1Phase 1 1Phase 3 2Phase 4 1No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Comparison of Sepsis Prediction AlgorithmsNot yet recruitingNCT05943938
• Parafilm to Prevent CLABSI in Pediatric Patients Undergoing HCTCompletedNCT02575079Not applicableResults posted
• Micronutrient Sprinkles in a Daycare CenterCompletedNCT00967551Phase 3Results posted
• Precision Resuscitation With Crystalloids in SepsisCompletedNCT06253585Not applicable
• Novel Sepsis Sub-phenotypes Based on Trajectories of Vital SignsCompletedNCT05826223
• Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)WithdrawnNCT04361552Phase 3
• Rifaximin for Infection Prophylaxis in Hematopoietic Stem Cell TransplantationCompletedNCT03529825Early Phase 1
• FMT for MDRO Colonization After Infection in Renal Transplant RecipientsTerminatedNCT02922816Phase 1
• Antibiotics and Tissue Expanders in Breast ReconstructionWithdrawnNCT01899690Phase 4
• Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone HomeostasisCompletedNCT01020045
• Comparison of Infection Rates Among Patients Using Two Catheter Access DevicesCompletedNCT00965198
• A Comparison of Redrubber Versus Penrose DrainsCompletedNCT00645957Not applicable
• Pro-Calcitonin Levels Following Pediatric Cardiac SurgeryCompletedNCT00284570
• Immune Response to Hepatitis C VirusWithdrawnNCT00165919